54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 28
00:41 UTC
|
FBRX
Forte Biosciences
|
↓ Downgrade | firm only | Hold | |
|
Jul 28
00:41 UTC
|
DBM
Doman Building Materials Group
|
↓ Downgrade | firm only | Strong-Buy→ Outperform | C$12.00 |
|
Jul 28
00:41 UTC
|
CORZ
Core Scientific
|
↓ Downgrade | firm only | Outperform→ Market Perform | $25.00 |
|
Jul 28
00:41 UTC
|
CHKP
Check Point Software Technologies
|
↓ Downgrade | Brian Essex ★★★☆☆ #1338 | Overweight→ Neutral | $135.00 |
|
Jul 28
00:41 UTC
|
CAT
Caterpillar
|
↓ Downgrade | firm only | Buy→ Hold | |
|
Jul 28
00:41 UTC
|
CAPR
Capricor Therapeutics
|
↓ Downgrade | Boobalan Pachaiyappan ★☆☆☆☆ #3038 | Buy→ Neutral | $7.00 |
|
Jul 28
00:41 UTC
|
X
TMX Group
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Outperform | C$65.00→ C$63.00-3.1% |
|
Jul 28
00:41 UTC
|
V
Visa
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Jul 28
00:41 UTC
|
SDLF
Standard Life
|
↑ Upgrade | firm only | Sec→ r perform | GBX 870→ GBX 885+1.7% |
|
Jul 28
00:41 UTC
|
RKLB
Rocket Lab
|
↑ Upgrade | Rob Chang not yet tracked | Neutral→ Outperform | $107.00 |
|
Jul 28
00:41 UTC
|
RIVN
Rivian Automotive
|
↑ Upgrade | Alexander Potter ★☆☆☆☆ #3126 | Neutral→ Overweight | $18.00→ $20.00+11.1% |
|
Jul 28
00:41 UTC
|
RHI
Robert Half
|
↑ Upgrade | firm only | Market Perform→ Outperform | $47.00 |
|
Jul 28
00:41 UTC
|
PYPL
PayPal
|
↑ Upgrade | Bryan Keane ★★★★☆ #511 | Neutral→ Hold | |
|
Jul 28
00:41 UTC
|
PROF
Profound Medical
|
↑ Upgrade | firm only | Outperform→ Strong-Buy | $11.00 |
|
Jul 28
00:41 UTC
|
OTLK
Oncobiologics
|
↑ Upgrade | Julian Harrison ★☆☆☆☆ #2926 | Neutral→ Buy | $4.00 |
|
Jul 28
00:41 UTC
|
MBLY
Mobileye Global
|
↑ Upgrade | Alexander Potter ★☆☆☆☆ #3126 | Neutral→ Overweight | $10.00→ $12.00+20.0% |
|
Jul 28
00:41 UTC
|
HOC
Hochschild Mining
|
↑ Upgrade | firm only | Buy | GBX 570 |
|
Jul 28
00:41 UTC
|
GM
General Motors
|
↑ Upgrade | Philippe Houchois ★★★☆☆ #1874 | Hold→ Buy | $90.00→ $99.00+10.0% |
|
Jul 28
00:41 UTC
|
F
Ford Motor
|
↑ Upgrade | Philippe Houchois ★★★☆☆ #1874 | Hold→ Buy | $14.50→ $17.50+20.7% |
|
Jul 28
00:41 UTC
|
DSCSY
Disco
|
↑ Upgrade | firm only | Buy | |
|
Jul 28
00:41 UTC
|
CYD
China Yuchai International
|
↑ Upgrade | firm only | Buy | |
|
Jul 28
00:41 UTC
|
CCO
Cameco
|
↑ Upgrade | firm only | Neutral→ Buy | C$166.00 |
|
Jul 27
22:41 UTC
|
XROLF
Xero
|
↓ Downgrade | firm only | Outperform→ Sector Perform | |
|
Jul 27
20:40 UTC
|
THC
Tenet Healthcare
|
◎ Target | A.J. Rice ★★★★★ #322 | Buy | $288.00→ $308.00+6.9% |
|
Jul 27
20:40 UTC
|
STM
STMicroelectronics
|
◎ Target | Alexander Duval ★★☆☆☆ #2299 | Neutral | $67.50→ $60.50-10.4% |
|
Jul 27
20:40 UTC
|
PRKS
United Parks & Resorts
|
◎ Target | Lizzie Dove ★★★★☆ #728 | Neutral | $37.00→ $41.00+10.8% |
|
Jul 27
20:40 UTC
|
CAPR
Capricor Therapeutics
|
↓ Downgrade | Boobalan Pachaiyappan ★☆☆☆☆ #3038 | Buy→ Neutral | $7.00 |
|
Jul 27
20:40 UTC
|
PYPL
PayPal
|
↑ Upgrade | Bryan Keane ★★★★☆ #511 | Neutral→ Hold | |
|
Jul 27
19:40 UTC
|
SXT
Sensient Technologies
|
◎ Target | Joshua Spector ★★★☆☆ #1742 | Buy | $143.00→ $155.00+8.4% |
|
Jul 27
19:40 UTC
|
PSX
Phillips 66
|
◎ Target | Manav Gupta ★★★☆☆ #978 | Buy | $212.00→ $235.00+10.8% |
|
Jul 27
19:40 UTC
|
HCA
HCA Healthcare
|
◎ Target | A.J. Rice ★★★★★ #322 | Buy | $635.00→ $579.00-8.8% |
|
Jul 27
19:40 UTC
|
HAL
Halliburton
|
◎ Target | Josh Silverstein ★★☆☆☆ #2293 | Neutral | $40.00→ $39.00-2.5% |
|
Jul 27
19:40 UTC
|
GSHD
Goosehead Insurance
|
◎ Target | Brian Meredith ★★★★★ #183 | Buy | $70.00→ $72.00+2.9% |
|
Jul 27
19:40 UTC
|
FIX
Comfort Systems USA
|
◎ Target | Joshua Chan ★★★☆☆ #1389 | Buy | $2,125.00→ $2,225.00+4.7% |
|
Jul 27
19:40 UTC
|
CHKP
Check Point Software Technologies
|
◎ Target | Tal Liani ★★★★☆ #870 | Neutral | $120.00→ $140.00+16.7% |
|
Jul 27
19:40 UTC
|
BAH
Booz Allen Hamilton
|
◎ Target | Gavin Parsons ★★★☆☆ #1861 | Neutral | $70.00→ $78.00+11.4% |
|
Jul 27
19:40 UTC
|
VALE
Vale
|
↓ Downgrade | Marcio Farid ★★★☆☆ #1888 | Buy→ Neutral | $18.00→ $16.00-11.1% |
|
Jul 27
18:40 UTC
|
ZTS
Zoetis
|
◎ Target | Andrea Alfonso ★★★★☆ #666 | Neutral | $99.00→ $85.00-14.1% |
|
Jul 27
18:40 UTC
|
WTBA
West Bancorporation
|
◎ Target | Nathan Race ★★★★★ #242 | Neutral | $27.00→ $30.00+11.1% |
|
Jul 27
18:40 UTC
|
WEF
Western Forest Products
|
◎ Target | firm only | Market Perform | C$12.50→ C$20.00+60.0% |
|
Jul 27
18:40 UTC
|
UVE
Universal Insurance
|
◎ Target | Paul Newsome ★★★★★ #157 | Neutral | $44.00→ $45.00+2.3% |
|
Jul 27
18:40 UTC
|
USCB
USCB Financial
|
◎ Target | Stephen Scouten ★★★★☆ #433 | Overweight | $24.00→ $27.00+12.5% |
|
Jul 27
18:40 UTC
|
TSU
Trisura Group
|
◎ Target | firm only | Outperform | C$59.00→ C$60.00+1.7% |
|
Jul 27
18:40 UTC
|
TMO
Thermo Fisher Scientific
|
◎ Target | David Westenberg ★★★★★ #71 | Neutral | $510.00→ $600.00+17.6% |
|
Jul 27
18:40 UTC
|
TGTX
TG Therapeutics
|
◎ Target | William Woods not yet tracked | Buy | $55.00→ $86.00+56.4% |
|
Jul 27
18:40 UTC
|
TCBK
TriCo Bancshares
|
◎ Target | Matthew Clark ★★★☆☆ #975 | Neutral | $61.00→ $63.00+3.3% |
|
Jul 27
18:40 UTC
|
STBA
S&T Bancorp
|
◎ Target | Justin Crowley ★★★★★ #90 | Neutral | $51.00→ $53.00+3.9% |
|
Jul 27
18:40 UTC
|
SSB
SouthState Bank
|
◎ Target | Stephen Scouten ★★★★☆ #433 | Overweight | $120.00→ $125.00+4.2% |
|
Jul 27
18:40 UTC
|
SJ
Stella-Jones
|
◎ Target | firm only | Outperform | C$95.00→ C$90.00-5.3% |
|
Jul 27
18:40 UTC
|
SHBI
Shore Bancshares
|
◎ Target | Justin Crowley ★★★★★ #90 | Overweight | $24.00→ $26.50+10.4% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.